Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis

NCT: NCT07516184 · RECRUITING

NCT IDNCT07516184
StatusRECRUITING
Start Date2026-06-10
Completion2027-06-11
SponsorAstraZeneca (INDUSTRY)
First posted
Last updated

Brief Summary

This is a multi-center study to explore the positive predictive value of bronchodilation test with portable oscillometry compared to either BDT or BPT with spirometry in asthma diagnosis and to compare it with bronchodilation with spirometry (the current gold standard). In the study, the target patients' profile is the suspected asthma patient with asthmatic symptoms (wheezing, shortness of breath, chest tightness, and/or cough) and aim to enroll 500 participants from 25 sites across different regions in China.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑